Background: Pulmonary hydatid cyst (PHC) is a parasitic infectious disease, that is endemic in various regions worldwide. Thoracoscopic treatmentremains the treatment of choice for PHC. The objective of this study is to assess the feasibility of video-assisted thoracic surgery (VATS) and compare the outcomes of patients undergoing uniportal VATS (U-VATS)with those undergoing multiportal VATS(M-VATS) for the treatment of PHC. Methods: A retrospective analysis of medical records from 134 patients whounderwent VATSfor PHC between January 2018 and January 2022 was conducted. Among them, 90 (67%) patients who underwent M-VATS, while 44 (33%) patients underwent U-VATS. Parameters including patient characteristics, cyst diameter, surgical duration, time to drain removal, length of hospital stay and complications were compared between the M-VATS and U-VATS groups. Results: There were no significant differences in patient characteristics, cyst diameter and surgical duration between the two groups. The time to drain removal and length of hospital stay in the U-VATS group were significantly shorter than those of the M-VATS group. Postoperative complications were not significantly different between the two groups. There was no postoperative mortality in either group. Throughout the follow-up period, no recurrence was observed in either group. Conclusions: VATS with uni or multiportal was determined to be a safe and effective technique for the treatment of PHC and can serve as an alternative to traditional thoracotomy.
Background: Pulmonary hydatid cyst (PHC) is a parasitic infectious disease, that is endemic in various regions worldwide. Thoracoscopic treatmentremains the treatment of choice for PHC. The objective of this study is to assess the feasibility of video-assisted thoracic surgery (VATS) and compare the outcomes of patients undergoing uniportal VATS (U-VATS)with those undergoing multiportal VATS(M-VATS) for the treatment of PHC. Methods: A retrospective analysis of medical records from 134 patients whounderwent VATSfor PHC between January 2018 and January 2022 was conducted. Among them, 90 (67%) patients who underwent M-VATS, while 44 (33%) patients underwent U-VATS. Parameters including patient characteristics, cyst diameter, surgical duration, time to drain removal, length of hospital stay and complications were compared between the M-VATS and U-VATS groups. Results: There were no significant differences in patient characteristics, cyst diameter and surgical duration between the two groups. The time to drain removal and length of hospital stay in the U-VATS group were significantly shorter than those of the M-VATS group. Postoperative complications were not significantly different between the two groups. There was no postoperative mortality in either group. Throughout the follow-up period, no recurrence was observed in either group. Conclusions: VATS with uni or multiportal was determined to be a safe and effective technique for the treatment of PHC and can serve as an alternative to traditional thoracotomy.